相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
R. Kodera et al.
DIABETOLOGIA (2011)
Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy
Lyubov Chaykovska et al.
PLOS ONE (2011)
Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species-Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
Hisko Oeseburg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Masayuki Arakawa et al.
DIABETES (2010)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation
Fernando Dorado et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
Cheol Whee Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Therapeutic potential of angiostatin in diabetic nephropathy
Sarah X. Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice
P Roestenberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats
BR Gedulin et al.
DIABETOLOGIA (2005)
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
T Nyström et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-β-independent pathway
S Lam et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes
J Dupré et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
PL Brubaker et al.
ENDOCRINOLOGY (2004)
Synthetic exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
OG Kolterman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Inhibition of the JAK/STAT signaling pathway prevents the high glucose-induced increase in TGF-β and fibronectin synthesis in mesangial cells
XD Wang et al.
DIABETES (2002)
CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC
YJ Chen et al.
KIDNEY INTERNATIONAL (2002)
Transforming growth factor-β and connective tissue growth factor:: key cytokines in scleroderma pathogenesis
CP Denton et al.
CURRENT OPINION IN RHEUMATOLOGY (2001)
Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy
NA Wahab et al.
BIOCHEMICAL JOURNAL (2001)
Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy
SN Wang et al.
KIDNEY INTERNATIONAL (2001)
In vitro evidence for differential involvement of CTGF, TGFβ, and PDGF-BB in mesangial response to injury
IE Blom et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
The control of ccn2*(ctgf) gene expression in normal and scleroderma fibroblasts
A Leask et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro
DG Parkes et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Platelet-derived growth factor, basic fibroblast growth factor, and interferon γ increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-β-dependent mechanism
H Yamabe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats
M Szayna et al.
ENDOCRINOLOGY (2000)
Connective tissue growth factor: What's in a name?
EEDA Moussad et al.
MOLECULAR GENETICS AND METABOLISM (2000)